No Cover Image

Journal article 48 views 8 downloads

A liver function test pathway significantly increases the early detection of chronic liver disease and cirrhosis

Jingwei Gao, Haroon Ahmed Orcid Logo, Rebecca Cannings-John Orcid Logo, Ashley Akbari Orcid Logo, Aled Davies Orcid Logo, Thomas Peter I. Pembroke Orcid Logo

Hepatology Communications, Volume: 10, Issue: 2

Swansea University Authors: Jingwei Gao, Ashley Akbari Orcid Logo

  • 71358.VoR.pdf

    PDF | Version of Record

    © 2026 The Author(s). This is an open access article distributed under the Creative Commons Attribution License 4.0 (CC BY).

    Download (2.32MB)

Abstract

Background: To enhance early liver disease detection, a clinical pathway integrating reflex AST testing and automated AAR reporting was implemented. We aim to evaluate the long-term effectiveness of introducing reflex AST testing by assessing its impact after implementation in 2 regions of Wales.Met...

Full description

Published in: Hepatology Communications
ISSN: 2471-254X
Published: Ovid Technologies (Wolters Kluwer Health) 2026
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa71358
Abstract: Background: To enhance early liver disease detection, a clinical pathway integrating reflex AST testing and automated AAR reporting was implemented. We aim to evaluate the long-term effectiveness of introducing reflex AST testing by assessing its impact after implementation in 2 regions of Wales.Methods: We applied a quasi-experimental, Difference-in-Difference approach to evaluate the introduction of the reflex AST:ALT pathway in Wales (January 2010 to December 2023). Outcomes were the monthly incidence rate of (1) chronic liver disease (including cirrhosis) and (2) cirrhosis in the 2 intervention regions versus the control regions.Results: In total, 78,917 individuals with liver disease were included in the study. A significant increase in cirrhosis diagnoses was observed in both regions (first region: incidence rate ratio=1.24, 95% CI: 1.15–1.34, p<0.001; second region: incidence rate ratio=1.16, 95% CI: 1.02–1.33, p=0.028). The incidence of composite chronic liver disease (including cirrhosis) increased transiently in the second region only (incidence rate ratio=1.35, 95% CI: 1.16–1.56, p<0.001).Conclusions: In this long-term, population-level evaluation, reflex AST:ALT testing increased cirrhosis detection in both regions and produced a short-term rise in chronic liver disease (including cirrhosis) diagnoses one region, strengthening the evidence of the pathway’s effect on cirrhosis detection. Further study is warranted to understand regional variation.
Keywords: aspartate aminotransferases, clinical pathways, liver cirrhosis, liver diseases, primary health care
College: Faculty of Medicine, Health and Life Sciences
Funders: This project was partly funded by an unrestricted grant from the Liver Disease Implementation Group, Welsh Government (LDIG-22-19).
Issue: 2